Trinity Biotech plc (TRIB)
NASDAQ: TRIB · Real-Time Price · USD
0.6410
-0.0265 (-3.97%)
At close: Mar 28, 2025, 4:00 PM
0.6615
+0.0205 (3.19%)
After-hours: Mar 28, 2025, 7:50 PM EDT
Trinity Biotech Revenue
Trinity Biotech had revenue of $15.15M in the quarter ending September 30, 2024, with 3.24% growth. This brings the company's revenue in the last twelve months to $59.13M, down -17.18% year-over-year. In the year 2023, Trinity Biotech had annual revenue of $56.83M, down -9.10%.
Revenue (ttm)
$59.13M
Revenue Growth
-17.18%
P/S Ratio
0.10
Revenue / Employee
$155,595
Employees
380
Market Cap
11.17M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 56.83M | -5.69M | -9.10% |
Dec 31, 2022 | 62.52M | -18.63M | -22.96% |
Dec 31, 2021 | 81.15M | -20.83M | -20.43% |
Dec 31, 2020 | 101.98M | 11.55M | 12.77% |
Dec 31, 2019 | 90.44M | -6.60M | -6.80% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionTRIB News
- 16 days ago - Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares and Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 17 days ago - Trinity Biotech Further Strengthens Focus on Continuous Glucose Monitoring – Appoints Barclays to Advise on Ongoing Strategic Realignment Process - GlobeNewsWire
- 4 weeks ago - Trinity Biotech Announces Additional Funding To Support Transformation Plan & Continued Development of the Company's Continuous Glucose Monitoring Technology - GlobeNewsWire
- 7 weeks ago - Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial - GlobeNewsWire
- 2 months ago - Trinity Biotech Announces Breakthrough Results From Pre-Pivotal Trial of Disruptive Continuous Glucose Monitoring (CGM) Technology - GlobeNewsWire
- 3 months ago - Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation Plan - GlobeNewsWire
- 3 months ago - Trinity Biotech Receives Early Approval from the World Health Organization to Begin Offshore Manufacturing of TrinScreen HIV & Uni-Gold HIV - GlobeNewsWire
- 4 months ago - Trinity Biotech Plc (TRIB) Q3 2024 Earnings Call Transcript - Seeking Alpha